Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma-Reference-Cited by-同舟云学术

Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma

Published:2023-06 Issue:6 Volume:299 Page:104814
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Hong Xuan^ORCID,Hsieh Min-Tsang,Tseng Tzu-Yu,Lin Hui-Yi,Chang Hung-Chih,Yau Sir-Theng^ORCID,Cheng Wei-Chung^ORCID,Ke Baozhen,Liao Hsiao-Hui,Wu Chih-Ying^ORCID,Liu An-An^ORCID,Wu Meei-Maan^ORCID,Huang Kuo-Yen^ORCID,Yang Pan-Chyr,Kuo Sheng-Chu,Hung Mien-Chie,Lee Pei-Chih^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference100 articles.

1. Lung cancer 2020: epidemiology, etiology, and prevention;Bade;Clin. Chest Med.,2020

2. Understanding lineage plasticity as a path to targeted therapy failure in EGFR-mutant non-small cell lung cancer;Shaurova;Front. Genet.,2020

3. EGFR targeted therapy in lung cancer; an evolving story;Bartholomew;Respir. Med. Case Rep.,2017

4. The latest battles between EGFR monoclonal antibodies and resistant tumor cells;Cai;Front. Oncol.,2020

5. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer;Hsu;Cancer Metastasis Rev.,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4,4‐Diallyl curcumin bis(2,2‐hydroxymethyl)propanoate ameliorates nonalcoholic steatohepatitis in methionine‐choline‐deficient diet and Western diet mouse models;Chemical Biology & Drug Design;2024-05

2. Role of natural products in tumor therapy from basic research and clinical perspectives;Acta Materia Medica;2024

3. Identification and validation of eight lysosomes-related genes signatures and correlation with immune cell infiltration in lung adenocarcinoma;Cancer Cell International;2023-12-13